[1]
N. A. Luna, J. Quinitio, E. Erick, S. Kho, and P. Caguioa, “INCIDENCE AND ASSOCIATED CLINICAL FACTORS OF THYROID DYSFUNCTION DURING TYROSINE KINASE INHIBITOR THERAPY AMONG NONTHYROIDAL CANCER PATIENTS: A RETROSPECTIVE STUDY”, J ASEAN Fed Endocr Soc, vol. 37, no. 2, p. 14, Oct. 2022.